Who are Sodium Ferric Gluconate Complex in Sucrose.'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Feraheme, IRON SUCROSE, SUCROSE.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sodium-ferric-gluconate-complex-in-sucrose.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Sodium Ferric Gluconate Complex in Sucrose. — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sodium Ferric Gluconate Complex in Sucrose. (Sodium Ferric Gluconate Complex in Sucrose.) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Parenteral Iron Replacement [EPC].

marketed Parenteral Iron Replacement [EPC] Small molecule Live · refreshed every 30 min

Target snapshot

Sodium Ferric Gluconate Complex in Sucrose. (Sodium Ferric Gluconate Complex in Sucrose.) — Watson Pharmaceuticals. Sodium ferric gluconate complex in sucrose injection replenishes iron, essential for hemoglobin synthesis and oxygen transport.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Approval / PDUFA
Sodium Ferric Gluconate Complex in Sucrose. TARGET	Sodium Ferric Gluconate Complex in Sucrose.	Watson Pharmaceuticals	marketed	Parenteral Iron Replacement [EPC]
Feraheme	FERUMOXYTOL	Covis	marketed	Parenteral Iron Replacement [EPC]	2009-01-01
IRON SUCROSE	IRON SUCROSE		marketed	Parenteral Iron Replacement [EPC]	2000-01-01
SUCROSE	SUCROSE		marketed	Parenteral Iron Replacement [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Parenteral Iron Replacement [EPC] class)

· 2 drugs in this class
Covis · 1 drug in this class
Watson Pharmaceuticals · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sodium Ferric Gluconate Complex in Sucrose. — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-ferric-gluconate-complex-in-sucrose. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab